Transcriptional control of the development and function of vα14i NKT cells

Current Topics in Microbiology and Immunology

Volumn 381, Issue , 2014, Pages 51-81

  Engel, Isaac ^a   Kronenberg, Mitchell ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CD24 ANTIGEN; E PROTEIN; EARLY GROWTH RESPONSE FACTOR; GAMMA INTERFERON; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF DIFFERENTIATION PROTEIN; INTERLEUKIN 15; INTERLEUKIN 17; PEPTIDES AND PROTEINS; PROTEIN C MYB; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR PLZF; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR;

ADAPTIVE IMMUNITY; ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELLULAR DISTRIBUTION; EFFECTOR CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER T CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH1 CELL; TH17 CELL; TH2 CELL; THYMOCYTE; THYMUS; TRANSCRIPTION REGULATION; VALPHA14 INVARIANT NATURAL KILLER T CELL; ANIMAL; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

ANIMALS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84922197046     PISSN: 0070217X     EISSN: 21969965     Source Type: Book Series    
DOI: 10.1007/82_2014_375     Document Type: Article

References (148)

1. Alberola-Ila J, Forbush KA, Seger R, Krebs EG, Perlmutter RM (1995) Selective requirement forMAP kinase activation in thymocyte differentiation. Nature 373(6515):620–623
2. Albu DI, Feng D, Bhattacharya D, Jenkins NA, Copeland NG, Liu P, Avram D (2007) BCL11B is required for positive selection and survival of double-positive thymocytes. J Exp Med204(12):3003–3015. doi:10.1084/jem.20070863
3. Albu DI, Van Valkenburgh J, Morin N, Califano D, Jenkins NA, Copeland NG, Liu P, Avram D (2011) Transcription factor Bcl11b controls selection of invariant natural killer T-cells by regulating glycolipid presentation in double-positive thymocytes. Proc Natl Acad Sci USA108(15):6211–6216. doi:10.1073/pnas.1014304108
4. Aliahmad P, Kaye J (2008) Development of all CD4 T lineages requires nuclear factor TOX.J Exp Med 205(1):245–256
5. Alonzo ES, Gottschalk RA, Das J, Egawa T, Hobbs RM, Pandolfi PP, Pereira P, Nichols KE, Koretzky GA, Jordan MS, Sant’Angelo DB (2010) Development of promyelocytic zinc finger and ThPOK-expressing innate gamma delta T cells is controlled by strength of TCR signalingand Id3. J Immunol 184(3):1268–1279. doi:10.4049/jimmunol.0903218
6. Atherly LO, Lucas JA, Felices M, Yin CC, Reiner SL, Berg LJ (2006) The Tec family tyrosine kinases Itk and Rlk regulate the development of conventional CD8+ T cells. Immunity25(1):79–91. doi:10.1016/j.immuni.2006.05.012
7. Bain G, Cravatt CB, Loomans C, Alberola-Ila J, Hedrick SM, Murre C (2001) Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade. Nat Immunol 2(2):165–171
8. Bendelac A, Killeen N, Littman DR, Schwartz RH (1994) A subset of CD4+ thymocytes selected by MHC class I molecules. Science 263(5154):1774–1778
9. Bendelac A, Lantz O, Quimby ME, Yewdell JW, Bennink JR, Brutkiewicz RR (1995) CD1 recognition by mouse NK1+ T lymphocytes. Science 268(5212):863–865
10. Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A (2000) In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med 191(11):1895–1903
11. Benlagha K, Kyin T, Beavis A, Teyton L, Bendelac A (2002) A thymic precursor to the NK T cell lineage. Science 296(5567):553–555
12. Benlagha K, Wei DG, Veiga J, Teyton L, Bendelac A (2005) Characterization of the early stages of thymic NKT cell development. J Exp Med 202(4):485–492
13. Betz BC, Jordan-Williams KL, Wang C, Kang SG, Liao J, Logan MR, Kim CH, Taparowsky EJ (2010) Batf coordinates multiple aspects of B and T cell function required for normal antibody responses. J Exp Med 207(5):933–942. doi:10.1084/jem.20091548
14. Bezbradica JS, Hill T, Stanic AK, Van Kaer L, Joyce S (2005) Commitment toward the natural T (iNKT) cell lineage occurs at the CD4+8+ stage of thymic ontogeny. Proc Natl Acad Sci USA 102(14):5114–5119
15. Bonneville M, O’Brien RL, Born WK (2010) Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol 10(7):467–478. doi:10.1038/nri2781
16. Brossay L, Chioda M, Burdin N, Koezuka Y, Casorati G, Dellabona P, Kronenberg M (1998) CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med 188(8):1521–1528
17. Broussard C, Fleischacker C, Horai R, Chetana M, Venegas AM, Sharp LL, Hedrick SM, Fowlkes BJ, Schwartzberg PL (2006) Altered development of CD8+ T cell lineages in mice deficient for the Tec kinases Itk and Rlk. Immunity 25(1):93–104. doi:10.1016/j.immuni.2006.05.011
18. Bueno OF, Brandt EB, Rothenberg ME, Molkentin JD (2002) Defective T cell development and function in calcineurin A beta -deficient mice. Proc Natl Acad Sci USA 99(14):9398–9403. doi:10.1073/pnas.152665399
19. Burdin N, Brossay L, Koezuka Y, Smiley ST, Grusby MJ, Gui M, Taniguchi M, Hayakawa K, Kronenberg M (1998) Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. J Immunol161(7):3271–3281
20. Carpenter AC, Grainger JR, Xiong Y, Kanno Y, Chu HH, Wang L, Naik S, dos Santos L, Wei L, Jenkins MK, O’Shea JJ, Belkaid Y, Bosselut R (2012) The transcription factors Thpok and LRF are necessary and partly redundant for T helper cell differentiation. Immunity37(4):622–633. doi:10.1016/j.immuni.2012.06.019
21. Chang PP, Barral P, Fitch J, Pratama A, Ma CS, Kallies A, Hogan JJ, Cerundolo V, Tangye SG, Bittman R, Nutt SL, Brink R, Godfrey DI, Batista FD, Vinuesa CG (2011) Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses.Nat Immunol 13(1):35–43. doi:10.1038/ni.2166
22. Choi HJ, Geng Y, Cho H, Li S, Giri PK, Felio K, Wang CR (2011) Differential requirements for the Ets transcription factor Elf-1 in the development of NKT cells and NK cells. Blood117(6):1880–1887. doi:10.1182/blood-2010-09-309468
23. Chung B, Aoukaty A, Dutz J, Terhorst C, Tan R (2005) Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. J Immunol 174(6):3153–3157
24. Ciofani M, Madar A, Galan C, Sellars M, Mace K, Pauli F, Agarwal A, Huang W, Parkurst CN, Muratet M, Newberry KM, Meadows S, Greenfield A, Yang Y, Jain P, Kirigin FK, Birchmeier C, Wagner EF, Murphy KM, Myers RM, Bonneau R, Littman DR (2012) A validated regulatory network for Th17 cell specification. Cell 151(2):289–303. doi:10.1016/j.cell.2012.09.016
25. Cohen NR, Brennan PJ, Shay T, Watts GF, Brigl M, Kang J, Brenner MB, ImmGen Project C (2013) Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells. Nat Immunol 14(1):90–99. doi:10.1038/ni.2490
26. Cui J, Shin T, Kawano T, Sato H, Kondo E, Toura I, Kaneko Y, Koseki H, Kanno M, Taniguchi M (1997) Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278(5343):1623–1626
27. D’Cruz LM, Knell J, Fujimoto JK, Goldrath AW (2010) An essential role for the transcription factor HEB in thymocyte survival, Tcra rearrangement and the development of natural killer T cells. Nat Immunol 11(3):240–249. doi:10.1038/ni.1845
28. D’Cruz LM, Stradner MH, Yang CY, Goldrath AW (2014) E and Id proteins influence invariant NKT cell sublineage differentiation and proliferation. J Immunol 192(5):2227–2236. doi:10.4049/jimmunol.1302904
29. Dao M, Nolta J (1999) Molecular control of cell cycle progression in primary human hematopoietic stem cells: methods to increase levels of retroviral-mediated transduction. Leukemia 13(10):1473–1480
30. Dashtsoodol N, Watarai H, Sakata S, Taniguchi M (2008) Identification of CD4(-)CD8(-) double-negative natural killer T cell precursors in the thymus. PLoS ONE 3(11):e3688. doi:10.1371/journal.pone.0003688
31. Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C, Li ZW, Karin M, Ware CF, Green DR (2002) The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17(4):525–535
32. Djuretic IM, Levanon D, Negreanu V, Groner Y, Rao A, Ansel KM (2007) Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat Immunol 8(2):145–153. doi:10.1038/ni1424
33. Doisne JM, Bartholin L, Yan KP, Garcia CN, Duarte N, Le Luduec JB, Vincent D, Cyprian F, Horvat B, Martel S, Rimokh R, Losson R, Benlagha K, Marie JC (2009) iNKT cell development is orchestrated by different branches of TGF-beta signaling. J Exp Med 206(6):1365–1378. doi:10.1084/jem.20090127
34. Dose M, Sleckman BP, Han J, Bredemeyer AL, Bendelac A, Gounari F (2009) Intrathymic proliferation wave essential for Valpha14+ natural killer T cell development depends on c-Myc. Proc Natl Acad Sci USA 106(21):8641–8646. doi:10.1073/pnas.0812255106
35. Dutta M, Kraus ZJ, Gomez-Rodriguez J, Hwang SH, Cannons JL, Cheng J, Lee SY, Wiest DL, Wakeland EK, Schwartzberg PL (2013) A role for Ly108 in the induction of promyelocytic zinc finger transcription factor in developing thymocytes. J Immunol 190(5):2121–2128. doi:10.4049/jimmunol.1202145
36. Eberl G, Lowin-Kropf B, MacDonald HR (1999) Cutting edge: NKT cell development is selectively impaired in Fyn-deficient mice. J Immunol 163(8):4091–4094
37. Egawa T, Eberl G, Taniuchi I, Benlagha K, Geissmann F, Hennighausen L, Bendelac A, Littman DR (2005) Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors. Immunity 22(6):705–716
38. Egawa T, Littman DR (2008) ThPOK acts late in specification of the helper T cell lineage and suppresses Runx-mediated commitment to the cytotoxic T cell lineage. Nat Immunol 9:1131–1139
39. Elewaut D, Shaikh RB, Hammond KJ, De Winter H, Leishman AJ, Sidobre S, Turovskaya O, Prigozy TI, Ma L, Banks TA, Lo D, Ware CF, Cheroutre H, Kronenberg M (2003) NIK-dependent RelB activation defines a unique signaling pathway for the development of V alpha 14i NKT cells. J Exp Med 197(12):1623–1633. doi:10.1084/jem.20030141
40. Enders A, Stankovic S, Teh C, Uldrich AP, Yabas M, Juelich T, Altin JA, Frankenreiter S, Bergmann H, Roots CM, Kyparissoudis K, Goodnow CC, Godfrey DI (2012) ZBTB7B (Th-POK) regulates the development of IL-17-producing CD1d-restricted mouse NKT cells. J Immunol 189(11):5240–5249. doi:10.4049/jimmunol.1201486
41. Engel I, Hammond K, Sullivan BA, He X, Taniuchi I, Kappes D, Kronenberg M (2010) Co-receptor choice by V alpha14i NKT cells is driven by Th-POK expression rather than avoidance of CD8-mediated negative selection. J Exp Med 207(5):1015–1029. doi:10.1084/jem.20090557
42. Engel I, Kronenberg M (2012) Making memory at birth: understanding the differentiation of natural killer T cells. Curr Opin Immunol 24(2):184–190. doi:10.1016/j.coi.2012.01.012
43. Engel I, Zhao M, Kappes D, Taniuchi I, Kronenberg M (2012) The transcription factor Th-POK negatively regulates Th17 differentiation in Valpha14i NKT cells. Blood 120(23):4524–4532. doi:10.1182/blood-2012-01-406280
44. Engelmann P, Farkas K, Kis J, Richman G, Zhang Z, Liew CW, Borowiec M, Niewczas MA, Jalahej H, Orban T (2011) Characterization of human invariant natural killer T cells expressing FoxP3. Int Immunol 23(8):473–484. doi:10.1093/intimm/dxr040
45. Exley M, Garcia J, Balk SP, Porcelli S (1997) Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells. J Exp Med 186(1):109–120
46. Fukuyama T, Kasper LH, Boussouar F, Jeevan T, van Deursen J, Brindle PK (2009) Histone acetyltransferase CBP is vital to demarcate conventional and innate CD8+ T-cell development. Mol Cell Biol 29(14):3894–3904. doi:10.1128/MCB.01598-08
47. Gadue P, Morton N, Stein PL (1999) The Src family tyrosine kinase Fyn regulates natural killer T cell development. J Exp Med 190(8):1189–1196
48. Gapin L, Godfrey DI, Rossjohn J (2013) Natural killer T cell obsession with self-antigens. Curr Opin Immunol 25(2):168–173. doi:10.1016/j.coi.2013.01.002
49. Geissmann F, Cameron TO, Sidobre S, Manlongat N, Kronenberg M, Briskin MJ, Dustin ML, Littman DR (2005) Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 3(4):e113. doi:10.1371/journal.pbio.0030113
50. Germanov E, Veinotte L, Cullen R, Chamberlain E, Butcher EC, Johnston B (2008) Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells. J Immunol 181(1):81–91
51. Gleimer M, von Boehmer H, Kreslavsky T (2012) PLZF controls the expression of a limited number of genes essential for NKT cell function. Front Immunol 3:374. doi:10.3389/fimmu.2012.00374
52. Gordy LE, Bezbradica JS, Flyak AI, Spencer CT, Dunkle A, Sun J, Stanic AK, Boothby MR, He YW, Zhao Z, Van Kaer L, Joyce S (2011) IL-15 regulates homeostasis and terminal maturation of NKT cells. J Immunol 187(12):6335–6345. doi:10.4049/jimmunol.1003965
53. Griewank K, Borowski C, Rietdijk S, Wang N, Julien A, Wei DG, Mamchak AA, Terhorst C, Bendelac A (2007) Homotypic interactions mediated by Slamf1 and Slamf6 receptors controlNKT cell lineage development. Immunity 27(5):751–762
54. Gumperz JE, Miyake S, Yamamura T, Brenner MB (2002) Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 195(5):625–636
55. Guo J, Hawwari A, Li H, Sun Z, Mahanta SK, Littman DR, Krangel MS, He YW (2002) Regulation of the TCRalpha repertoire by the survival window of CD4(+)CD8(+) thymocytes.Nat Immunol 3(5):469–476. doi:10.1038/ni791
56. Havenar-Daughton C, Li S, Benlagha K, Marie JC (2012) Development and function of murine RORgammat+ iNKT cells are under TGF-beta signaling control. Blood 119(15):3486–3494.doi:10.1182/blood-2012-01-401604
57. He X, He X, Dave VP, Zhang Y, Hua X, Nicolas E, Xu W, Roe BA, Kappes DJ (2005) The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment.Nature 433(7028):826–833
58. He X, Park K, Wang H, He X, Zhang Y, Hua X, Li Y, Kappes DJ (2008) CD4-CD8 lineage commitment is regulated by a silencer element at the ThPOK transcription-factor locus.Immunity 28(3):346–358
59. Hu T, Simmons A, Yuan J, Bender TP, Alberola-Ila J (2010) The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage. Nat Immunol11(5):435–441. doi:10.1038/ni.1865
60. Hu T, Gimferrer I, Simmons A, Wiest D, Alberola-Ila J (2011) The Ras/MAPK pathway is required for generation of iNKT cells. PLoS ONE 6(5):e19890. doi:10.1371/journal.pone.0019890
61. Hu T, Wang H, Simmons A, Bajana S, Zhao Y, Kovats S, Sun XH, Alberola-Ila J (2013) Increased level of E protein activity during invariant NKT development promotes differentiation of invariant NKT2 and invariant NKT17 subsets. J Immunol 191(10):5065–5073. doi:10.4049/jimmunol.1301546
62. Ishihara S, Nieda M, Kitayama J, Osada T, Yabe T, Ishikawa Y, Nagawa H, Muto T, Juji T (1999) CD8(+)NKR-P1A (+)T cells preferentially accumulate in human liver. Eur J Immunol 29(8):2406–2413. doi:10.1002/(SICI)1521-4141(199908)29:08\2406:AID-IMMU2406[3.0.CO;2-F
63. Jensen KD, Su X, Shin S, Li L, Youssef S, Yamasaki S, Steinman L, Saito T, Locksley RM, Davis MM, Baumgarth N, Chien YH (2008) Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. Immunity 29(1):90–100. doi:10.1016/j.immuni.2008.04.022
64. Jones ME, Zhuang Y (2009) Regulation of V(D)J recombination by E-protein transcription factors. Adv Exp Med Biol 650:148–156
65. Jordan MS, Smith JE, Burns JC, Austin JE, Nichols KE, Aschenbrenner AC, Koretzky GA (2008) Complementation in trans of altered thymocyte development in mice expressing mutant forms of the adaptor molecule SLP76. Immunity 28(3):359–369. doi:10.1016/j.immuni.2008.01.010
66. Jordan-Williams KL, Poston S, Taparowsky EJ (2013) BATF regulates the development and function of IL-17 producing iNKT cells. BMC Immunol 14:16. doi:10.1186/1471-2172-14-16
67. Kallies A, Xin A, Belz GT, Nutt SL (2009) Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses. Immunity 31(2):283–295. doi:10.1016/j.immuni.2009.06.021
68. Kallies A, Carotta S, Huntington ND, Bernard NJ, Tarlinton DM, Smyth MJ, Nutt SL (2011) A role for Blimp1 in the transcriptional network controlling natural killer cell maturation. Blood 117(6):1869–1879. doi:10.1182/blood-2010-08-303123
69. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, Koseki H, Taniguchi M (1997) CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278(5343):1626–1629
70. Kim PJ, Pai SY, Brigl M, Besra GS, Gumperz J, Ho IC (2006) GATA-3 regulates the development and function of invariant NKT cells. J Immunol 177(10):6650–6659
71. King IL, Fortier A, Tighe M, Dibble J, Watts GF, Veerapen N, Haberman AM, Besra GS, Mohrs M, Brenner MB, Leadbetter EA (2011) Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner. Nat Immunol 13(1):44–50. doi:10.1038/ni.2172
72. Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, Ho DD, Tsuji M, Kawahara K, Wong CH, Kronenberg M (2005) Recognition of bacterial glycosphingolipids by natural killer T cells.Nature 434(7032):520–525
73. Kovalovsky D, Uche OU, Eladad S, Hobbs RM, Yi W, Alonzo E, Chua K, Eidson M, Kim HJ, Im JS, Pandolfi PP, Sant’Angelo DB (2008) The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat Immunol9(9):1055–1064
74. Kovalovsky D, Alonzo ES, Uche OU, Eidson M, Nichols KE, Sant’Angelo DB (2010) PLZF induces the spontaneous acquisition of memory/effector functions in T cells independently ofNKT cell-related signals. J Immunol 184(12):6746–6755. doi:10.4049/jimmunol.1000776
75. Kronenberg M, Gapin L (2002) The unconventional lifestyle of NKT cells. Nat Rev Immunol2(8):557–568
76. Lacorazza HD, Miyazaki Y, Di Cristofano A, Deblasio A, Hedvat C, Zhang J, Cordon-Cardo C, Mao S, Pandolfi PP, Nimer SD (2002) The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells. Immunity17(4):437–449
77. Lai D, Zhu J, Wang T, Hu-Li J, Terabe M, Berzofsky JA, Clayberger C, Krensky AM (2011) KLF13 sustains thymic memory-like CD8(+) T cells in BALB/c mice by regulating IL-4-generating invariant natural killer T cells. J Exp Med 208(5):1093–1103. doi:10.1084/jem.20101527
78. Lantz O, Bendelac A (1994) An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J Exp Med 180(3):1097–1106
79. Lawson VJ, Maurice D, Silk JD, Cerundolo V, Weston K (2009) Aberrant selection and function of invariant NKT cells in the absence of AP-1 transcription factor Fra-2. J Immunol 183(4):2575–2584. doi:10.4049/jimmunol.0803577
80. Lazarevic V, Zullo AJ, Schweitzer MN, Staton TL, Gallo EM, Crabtree GR, Glimcher LH (2009) The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nat Immunol 10(3):306–313. doi:10.1038/ni.1696
81. Le Bourhis L, Mburu YK, Lantz O (2013) MAIT cells, surveyors of a new class of antigen: development and functions. Curr Opin Immunol 25(2):174–180. doi:10.1016/j.coi.2013.01.005
82. Lee PT, Putnam A, Benlagha K, Teyton L, Gottlieb PA, Bendelac A (2002) Testing the NKT cell hypothesis of human IDDM pathogenesis. J Clin Invest 110(6):793–800. doi:10.1172/JCI15832
83. Lee YJ, Holzapfel KL, Zhu J, Jameson SC, Hogquist KA (2013) Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat Immunol 14(11):1146–1154. doi:10.1038/ni.2731
84. Levitsky HI, Golumbek PT, Pardoll DM (1991) The fate of CD4-8- T cell receptor-alpha beta+ thymocytes. J Immunol 146(4):1113–1117
85. Li J, Wu D, Jiang N, Zhuang Y (2013) Combined deletion of id2 and id3 genes reveals multiple roles for e proteins in invariant NKT cell development and expansion. J Immunol 191(10):5052–5064. doi:10.4049/jimmunol.1301252
86. Li W, Kim MG, Gourley TS, McCarthy BP, Sant’Angelo DB, Chang CH (2005) An alternate pathway for CD4 T cell development: thymocyte-expressed MHC class II selects a distinct T cell population. Immunity 23(4):375–386
87. Mathew R, Seiler MP, Scanlon ST, Mao AP, Constantinides MG, Bertozzi-Villa C, Singer JD, Bendelac A (2012) BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs. Nature. doi:10.1038/nature11548
88. Matsuda JL, Gapin L (2005) Developmental program of mouse Valpha14i NKT cells. Curr OpinImmunol 17(2):122–130
89. Matsuda JL, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, Wang CR, Koezuka Y, Kronenberg M (2000) Tracking the response of natural killer T cells to a glycolipid antigenusing CD1d tetramers. J Exp Med 192(5):741–754
90. Matsuda JL, Gapin L, Sidobre S, Kieper WC, Tan JT, Ceredig R, Surh CD, Kronenberg M (2002)Homeostasis of V alpha 14i NKT cells. Nat Immunol 3(10):966–974
91. Matsuda JL, Gapin L, Baron JL, Sidobre S, Stetson DB, Mohrs M, Locksley RM, Kronenberg M (2003) Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo. Proc Natl Acad Sci USA 100(14):8395–8400
92. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C 3rd, Zhou D, Saint-Mezard P, Wang V, Gao Y, Yin N, Hoebe K, Schneewind O, Walker D, Beutler B, Teyton L, Savage PB, Bendelac A (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbialinfections. Nature 434(7032):525–529
93. McConnell MJ, Licht JD (2007) The PLZF gene of t (11;17)-associated APL. Curr Top MicrobiolImmunol 313:31–48
94. McNab FW, Berzins SP, Pellicci DG, Kyparissoudis K, Field K, Smyth MJ, Godfrey DI (2005) The influence of CD1d in postselection NKT cell maturation and homeostasis. J Immunol175(6):3762–3768
95. Michel ML, Mendes-da-Cruz D, Keller AC, Lochner M, Schneider E, Dy M, Eberl G, Leite-de-Moraes MC (2008) Critical role of ROR-gammat in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc Natl Acad Sci USA 105(50):19845–19850. doi:10.1073/pnas.0806472105
96. Milpied P, Massot B, Renand A, Diem S, Herbelin A, Leite-de-Moraes M, Rubio MT, Hermine O (2011) IL-17-producing invariant NKT cells in lymphoid organs are recent thymic emigrants identified by neuropilin-1 expression. Blood 118(11):2993–3002. doi:10.1182/blood-2011-01-329268
97. Monteiro M, Almeida CF, Agua-Doce A, Graca L (2013) Induced IL-17-producing invariant NKT cells require activation in presence of TGF-beta and IL-1beta. J Immunol 190(2):805–811. doi:10.4049/jimmunol.1201010
98. Monticelli LA, Yang Y, Knell J, D’Cruz LM, Cannarile MA, Engel I, Kronenberg M, Goldrath AW (2009) Transcriptional regulator Id2 controls survival of hepatic NKT cells. Proc Natl Acad Sci USA 106(46):19461–19466. doi:10.1073/pnas.0908249106
99. Moreira-Teixeira L, Resende M, Devergne O, Herbeuval JP, Hermine O, Schneider E, Dy M, Cordeiro-da-Silva A, Leite-de-Moraes MC (2012) Rapamycin combined with TGF-beta converts human invariant NKT cells into suppressive Foxp3+ regulatory cells. J Immunol 188(2):624–631. doi:10.4049/jimmunol.1102281
100. Motomura Y, Kitamura H, Hijikata A, Matsunaga Y, Matsumoto K, Inoue H, Atarashi K, Hori S, Watarai H, Zhu J, Taniguchi M, Kubo M (2011) The transcription factor E4BP4 regulates the production of IL-10 and IL-13 in CD4+ T cells. Nat Immunol 12(5):450–459. doi:10.1038/ni.2020
101. Mycko MP, Ferrero I, Wilson A, Jiang W, Bianchi T, Trumpp A, MacDonald HR (2009) Selective requirement for c-Myc at an early stage of V(alpha)14i NKT cell development. J Immunol 182(8):4641–4648. doi:10.4049/jimmunol.0803394
102. Naoe Y, Setoguchi R, Akiyama K, Muroi S, Kuroda M, Hatam F, Littman DR, Taniuchi I (2007) Repression of interleukin-4 in T helper type 1 cells by Runx/Cbf beta binding to the Il4 silencer. J Exp Med 204(8):1749–1755. doi:10.1084/jem.20062456
103. Neilson JR, Winslow MM, Hur EM, Crabtree GR (2004) Calcineurin B1 is essential for positive but not negative selection during thymocyte development. Immunity 20(3):255–266
104. Nichols KE, Hom J, Gong SY, Ganguly A, Ma CS, Cannons JL, Tangye SG, Schwartzberg PL, Koretzky GA, Stein PL (2005) Regulation of NKT cell development by SAP, the protein defective in XLP. Nat Med 11(3):340–345
105. Pasquier B, Yin L, Fondaneche MC, Relouzat F, Bloch-Queyrat C, Lambert N, Fischer A, de Saint-Basile G, Latour S (2005) Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J Exp Med 201(5):695–701
106. Pellicci DG, Hammond KJ, Uldrich AP, Baxter AG, Smyth MJ, Godfrey DI (2002) A natural killer T (NKT) cell developmental pathway involving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage. J Exp Med 195(7):835–844
107. Porcelli S, Yockey CE, Brenner MB, Balk SP (1993) Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J Exp Med 178(1):1–16
108. Raberger J, Schebesta A, Sakaguchi S, Boucheron N, Blomberg KE, Berglof A, Kolbe T, Smith CI, Rulicke T, Ellmeier W (2008) The transcriptional regulator PLZF induces the development of CD44 high memory phenotype T cells. Proc Natl Acad Sci USA 105(46):17919–17924. doi:10.1073/pnas.0805733105
109. Raifer H, Mahiny AJ, Bollig N, Petermann F, Hellhund A, Kellner K, Guralnik A, Reinhard K, Bothur E, Huber M, Bauer S, Lohning M, Kiss EA, Ganal SC, Diefenbach A, Korn T, Lohoff M (2012) Unlike alphabeta T cells, gammadelta T cells, LTi cells and NKT cells do not require IRF4 for the production of IL-17A and IL-22. Eur J Immunol 42(12):3189–3201. doi:10.1002/eji.201142155
110. Ranson T, Vosshenrich CA, Corcuff E, Richard O, Laloux V, Lehuen A, Di Santo JP (2003) IL-15 availability conditions homeostasis of peripheral natural killer T cells. Proc Natl Acad Sci USA 100(5):2663–2668
111. Rutishauser RL, Martins GA, Kalachikov S, Chandele A, Parish IA, Meffre E, Jacob J, Calame K, Kaech SM (2009) Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 31(2):296–308. doi:10.1016/j.immuni.2009.05.014
112. Savage AK, Constantinides MG, Han J, Picard D, Martin E, Li B, Lantz O, Bendelac A (2008) The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29(3):391–403
113. Savage AK, Constantinides MG, Bendelac A (2011) Promyelocytic leukemia zinc finger turns on the effector T cell program without requirement for agonist TCR signaling. J Immunol 186(10):5801–5806. doi:10.4049/jimmunol.1100119
114. Schmidt-Supprian M, Tian J, Grant EP, Pasparakis M, Maehr R, Ovaa H, Ploegh HL, Coyle AJ, Rajewsky K (2004) Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc Natl Acad Sci USA 101(13):4566–4571. doi:10.1073/pnas.0400885101
115. Schmolka N, Serre K, Grosso AR, Rei M, Pennington DJ, Gomes AQ, Silva-Santos B (2013) Epigenetic and transcriptional signatures of stable versus plastic differentiation of proinflam-matory gammadelta T cell subsets. Nat Immunol 14(10):1093–1100. doi:10.1038/ni.2702
116. Seiler MP, Mathew R, Liszewski MK, Spooner CJ, Barr K, Meng F, Singh H, Bendelac A (2012) Elevated and sustained expression of the transcription factors Egr1 and Egr2 controls NKT lineage differentiation in response to TCR signaling. Nat Immunol 13(3):264–271. doi:10.1038/ni.2230
117. Setoguchi R, Tachibana M, Naoe Y, Muroi S, Akiyama K, Tezuka C, Okuda T, Taniuchi I (2008) Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science 319(5864):822–825
118. Shimaoka T, Seino K, Kume N, Minami M, Nishime C, Suematsu M, Kita T, Taniguchi M, Matsushima K, Yonehara S (2007) Critical role for CXC chemokine ligand 16 (SR-PSOX) in Th1 response mediated by NKT cells. J Immunol 179(12):8172–8179
119. Shin H, Blackburn SD, Intlekofer AM, Kao C, Angelosanto JM, Reiner SL, Wherry EJ (2009) A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. Immunity 31(2):309–320. doi:10.1016/j.immuni.2009.06.019
120. Sivakumar V, Hammond KJL, Howells N, Pfeffer K, Weih F (2003) Differential requirement for Rel/nuclear factor {kappa}B family members in natural killer T cell development. J Exp Med197(12):1613–1621
121. Smith MA, Maurin M, Cho HI, Becknell B, Freud AG, Yu J, Wei S, Djeu J, Celis E, Caligiuri MA, Wright KL (2010) PRDM1/Blimp-1 controls effector cytokine production in human NK cells. J Immunol 185(10):6058–6067. doi:10.4049/jimmunol.1001682
122. Stanic AK, Bezbradica JS, Park JJ, Matsuki N, Mora AL, Van Kaer L, Boothby MR, Joyce S (2004) NF-kappa B controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes. J Immunol 172(4):2265–2273
123. Stankovic S, Gugasyan R, Kyparissoudis K, Grumont R, Banerjee A, Tsichlis P, Gerondakis S, Godfrey DI (2011) Distinct roles in NKT cell maturation and function for the different transcription factors in the classical NF-kappaB pathway. Immunol Cell Biol 89(2):294–303.doi:10.1038/icb.2010.93
124. Stetson DB, Mohrs M, Reinhardt RL, Baron JL, Wang ZE, Gapin L, Kronenberg M, Locksley RM (2003) Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapideffector function. J Exp Med 198(7):1069–1076
125. Stock P, Lombardi V, Kohlrautz V, Akbari O (2009) Induction of airway hyperreactivity by IL-25 is dependent on a subset of invariant NKT cells expressing IL-17RB. J Immunol182(8):5116–5122. doi:10.4049/jimmunol.0804213
126. Sun G, Liu X, Mercado P, Jenkinson SR, Kypriotou M, Feigenbaum L, Galera P, Bosselut R (2005) The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection. Nat Immunol 6(4):373–381
127. Swan KA, Alberola-Ila J, Gross JA, Appleby MW, Forbush KA, Thomas JF, Perlmutter RM (1995) Involvement of p21ras distinguishes positive and negative selection in thymocytes. EMBO J 14(2):276–285
128. Terashima A, Watarai H, Inoue S, Sekine E, Nakagawa R, Hase K, Iwamura C, Nakajima H, Nakayama T, Taniguchi M (2008) A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J Exp Med 205(12):2727–2733. doi:10.1084/jem.20080698
129. Townsend MJ, Weinmann AS, Matsuda JL, Salomon R, Farnham PJ, Biron CA, Gapin L, Glimcher LH (2004) T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 20(4):477–494
130. Uldrich AP, Patel O, Cameron G, Pellicci DG, Day EB, Sullivan LC, Kyparissoudis K, Kjer-Nielsen L, Vivian JP, Cao B, Brooks AG, Williams SJ, Illarionov P, Besra GS, Turner SJ, Porcelli SA, McCluskey J, Smyth MJ, Rossjohn J, Godfrey DI (2011) A semi-invariant Valpha10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties. Nat Immunol 12(7):616–623. doi:10.1038/ni.2051
131. Vallabhapurapu S, Karin M (2009) Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27:693–733. doi:10.1146/annurev.immunol.021908.132641
132. Vallabhapurapu S, Powolny-Budnicka I, Riemann M, Schmid RM, Paxian S, Pfeffer K, Korner H, Weih F (2008) Rel/NF-kappaB family member RelA regulates NK1.1- to NK1.1+ transition as well as IL-15-induced expansion of NKT cells. Eur J Immunol 38(12):3508–3519. doi:10.1002/eji.200737830
133. van Gisbergen KP, Kragten NA, Hertoghs KM, Wensveen FM, Jonjic S, Hamann J, Nolte MA, van Lier RA (2012) Mouse Hobit is a homolog of the transcriptional repressor Blimp-1 that regulates NKT cell effector differentiation. Nat Immunol 13(9):864–871. doi:10.1038/ni.2393
134. Verykokakis M, Boos MD, Bendelac A, Adams EJ, Pereira P, Kee BL (2010a) Inhibitor of DNA binding 3 limits development of murine slam-associated adaptor protein-dependent ‘‘innate’’ gammadelta T cells. PLoS ONE 5(2):e9303. doi:10.1371/journal.pone.0009303
135. Verykokakis M, Boos MD, Bendelac A, Kee BL (2010b) SAP protein-dependent natural killer T-like cells regulate the development of CD8(+) T cells with innate lymphocyte characteristics. Immunity 33(2):203–215. doi:10.1016/j.immuni.2010.07.013
136. Verykokakis M, Krishnamoorthy V, Iavarone A, Lasorella A, Sigvardsson M, Kee BL (2013) Essential functions for ID proteins at multiple checkpoints in invariant NKT Celldevelopment. J Immunol 191:5973–5983. doi:10.4049/jimmunol.1301521
137. Walker LJ, Kang YH, Smith MO, Tharmalingham H, Ramamurthy N, Fleming VM, Sahgal N, Leslie A, Oo Y, Geremia A, Scriba TJ, Hanekom WA, Lauer GM, Lantz O, Adams DH, Powrie F, Barnes E, Klenerman P (2012) Human MAIT and CD8alphaalpha cells develop from a pool of type-17 precommitted CD8+ T cells. Blood 119(2):422–433. doi:10.1182/blood-2011-05-353789
138. Walunas TL, Wang B, Wang CR, Leiden JM (2000) Cutting edge: the Ets1 transcription factor isrequired for the development of NK T cells in mice. J Immunol 164(6):2857–2860
139. Wang L, Wildt KF, Zhu J, Zhang X, Feigenbaum L, Tessarollo L, Paul WE, Fowlkes BJ, Bosselut R (2008) Distinct functions for the transcription factors GATA-3 and ThPOK during intrathymic differentiation of CD4(+) T cells. Nat Immunol 9(10):1122–1130. doi:10.1038/ni.1647
140. Wang L, Carr T, Xiong Y, Wildt KF, Zhu J, Feigenbaum L, Bendelac A, Bosselut R (2010) The sequential activity of Gata3 and Thpok is required for the differentiation of CD1d-restricted CD4+ NKT cells. Eur J Immunol 40(9):2385–2390. doi:10.1002/eji.201040534
141. Watarai H, Sekine-Kondo E, Shigeura T, Motomura Y, Yasuda T, Satoh R, Yoshida H, Kubo M, Kawamoto H, Koseki H, Taniguchi M (2012) Development and function of invariant natural killer T cells producing T(h)2- and T(h)17-cytokines. PLoS Biol 10(2):e1001255. doi:10.1371/journal.pbio.1001255
142. Wei DG, Lee H, Park S-H, Beaudoin L, Teyton L, Lehuen A, Bendelac A (2005) Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes. J Exp Med 202(2):239–248
143. Weinreich MA, Takada K, Skon C, Reiner SL, Jameson SC, Hogquist KA (2009) KLF2 transcription-factor deficiency in T cells results in unrestrained cytokine production and upregulation of bystander chemokine receptors. Immunity 31(1):122–130. doi:10.1016/j.immuni.2009.05.011
144. Weinreich MA, Odumade OA, Jameson SC, Hogquist KA (2010) T cells expressing the transcription factor PLZF regulate the development of memory-like CD8+ T cells. Nat Immunol 11(8):709–716. doi:10.1038/ni.1898
145. Williams KL, Zullo AJ, Kaplan MH, Brutkiewicz RR, Deppmann CD, Vinson C, Taparowsky EJ (2003) BATF transgenic mice reveal a role for activator protein-1 in NKT cell development. J Immunol 170(5):2417–2426
146. Yu S, Cantorna MT (2008) The vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci USA 105(13):5207–5212. doi:10.1073/pnas.0711558105
147. Yue X, Izcue A, Borggrefe T (2011) Essential role of mediator subunit Med1 in invariant natural killer T-cell development. Proc Natl Acad Sci USA 108(41):17105–17110. doi:10.1073/pnas.1109095108
148. Zullo AJ, Benlagha K, Bendelac A, Taparowsky EJ (2007) Sensitivity of NK1.1-negative NKT cells to transgenic BATF defines a role for activator protein-1 in the expansion and maturation of immature NKT cells in the thymus. J Immunol 178(1):58–66